- €3.45bn
- €4.02bn
- €1.20bn
Italy's DiaSorin first quarter revenue up 8%, confirms 2025 guidance
Brief: Diasorin Q1 Adj. EBITDA EUR 313 Mln
Italy - Factors to watch on May 6
Europe Research Roundup: AB Foods, Jet2, THG
Italy - Factors to watch on April 28
Europe Research Roundup: Alcon, Delivery Hero, Electrolux
Brief: Diasorin Gets Clearance From Fda For Second Blood Infection Panel On Liaison Plex
Italy - Factors to watch on March 17
Brief: China is no longer strategic for Diasorin, CEO says
Italy's DiaSorin ex-Covid revenue in line with guidance
Brief: Diasorin, Fy Adjusted EBITDA Eur 394 Mln
Italy - Factors to watch on March 14
Brief: Diasorin Shareholders Approve Enhanced Majority Voting System
Italy - Factors to watch on Feb. 28
Top of the Street: EssilorLuxottica, BPER, UBS, DiaSorin, Lifco and Indutrade
Europe Research Roundup: Adidas, L'Oreal, Next
RBC sees growth in IVD market, favours bioMérieux over Diasorin
Italy - Factors to watch on November 6
Refile: UPDATE 1-Diagnostics group DiaSorin's nine-month adjusted core profit up 6%